Burroughs Amy L.

Average Profitability
<0.0001%
Insider Buys Quantity
2
Insider Buys Sum
$252,060.00
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Burroughs Amy L.

According to the SEC Form 4 filings, Burroughs Amy L., being in a position of

  1. Chief Executive Officer at Terns Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 15450 shares for $110,468, and sold 0 shares,
    over all time since 2024-12-05, has bought 15450 shares for $110,468, and sold 0 shares.

The largest purchase of all time was on 2021-08-16 and amounted to 44950 shares of DiaMedica Therapeutics Inc. for $141,593.

Biography of Burroughs Amy L.

No biography is available at this moment.

2024-12-05PurchaseTerns Pharmaceuticals, Inc.
TERN
Chief Executive Officer
15,450
0.0201%
$7.15$110,468+3.18%
2021-08-16PurchaseDiaMedica Therapeutics Inc.
DMAC
director
44,950
0.2261%
$3.15$141,593-15.2%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.